Status:
COMPLETED
Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Hemoglobin Mutations
Erythrocyte Variants
Eligibility:
All Genders
18-65 years
Brief Summary
This study will collect blood samples for use in laboratory studies of malaria. The World Health Organization reports that 40 percent of the world's population is at risk for malaria, mostly in the po...
Detailed Description
This protocol is designed to provide a mechanism for investigators in the Laboratory of Malaria and Vector Research (LMVR) to collect and process peripheral blood samples from volunteer donors. Donors...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Normal volunteer or volunteer with a known or suspected erythrocyte mutation.
- Age greater than or equal to 18 and less than or equal to 65 years old.
- Weight greater than 110 pounds.
- Ability to sign the consent form.
- Willingness to comply with study procedures.
- EXCLUSION CRITERIA:
- Transfusion of any blood products within the past 90 days.
- Active bleeding.
- Clinically apparent and/or symptomatic anemia (pallor, orthostasis, etc).
- Self-reported history of HIV, Hepatitis B virus, or Hepatitis C virus infection.
- Severe chronic disease (e.g. end-stage renal failure, malignancy, etc).
- Significant medical history, physical examination, or laboratory test results indicating that the subject should not participate in a clinical trial.
Exclusion
Key Trial Info
Start Date :
January 11 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 20 2010
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00277849
Start Date
January 11 2006
End Date
July 20 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892